[TRANSLATED ARTICLE] Biological and immunosuppressive medications in pregnancy, breastfeeding and fertility in immune mediated diseases

CONCLUSIONS: In this context of chronic treatments with teratogenic potential, it is necessary to highlight the importance of pregnancy planning to select the safest drug. Given the quality of the available data, it is still necessary to continuously update the information, as well as to promote observational studies of cohorts of pregnant patients and men of childbearing age, including prospective studies, in order to generate more scientific evidence.PMID:36732114 | DOI:10.1016/j.farma.2022.12.016

Source: Farmacia Hospitalaria - February 2, 2023 Category: Drugs & Pharmacology Authors: Olatz Ibarra Barrueta Estela Garc ía Martín Piedad L ópez Sánchez Esther Ram írez Herráiz Vicente Merino Boh órquez Arantza Ais Larisgoitia Source Type: research